Gabriele Alessandrini
Gabriele Alessandrini
Regina Elena National Cancer Institute - Rome
Email verificata su
TitoloCitata daAnno
SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells
C Canino, F Mori, A Cambria, A Diamantini, S Germoni, G Alessandrini, ...
Oncogene 31 (26), 3148, 2012
A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer
E Bria, M Milella, I Sperduti, G Alessandrini, P Visca, F Corzani, ...
Lung Cancer 66 (3), 365-371, 2009
Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas
C Abbruzzese, S Mattarocci, L Pizzuti, AM Mileo, P Visca, B Antoniani, ...
Journal of experimental & clinical cancer research 31 (1), 4, 2012
Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma
M Cioce, F Ganci, V Canu, A Sacconi, F Mori, C Canino, E Korita, B Casini, ...
Oncogene 33 (46), 5319, 2014
Extrapleural pneumonectomy for malignant mesothelioma: an Italian multicenter retrospective study
L Spaggiari, G Marulli, P Bovolato, M Alloisio, V Pagan, A Oliaro, GB Ratto, ...
The Annals of thoracic surgery 97 (6), 1859-1865, 2014
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancer
E Bria, F Di Modugno, I Sperduti, P Iapicca, P Visca, G Alessandrini, ...
Oncotarget 5 (22), 11054, 2014
Intracellular presence of insulin and its phosphorylated receptor in non‐small cell lung cancer
S Mattarocci, C Abbruzzese, AM Mileo, P Visca, B Antoniani, ...
Journal of cellular physiology 221 (3), 766-770, 2009
Prognostic role of serum p53 antibodies in lung cancer
M Mattioni, S Soddu, A Prodosmo, P Visca, S Conti, G Alessandrini, ...
BMC cancer 15 (1), 148, 2015
Expert opinions of the first Italian consensus conference on the management of malignant pleural mesothelioma
C Pinto, A Ardizzoni, PG Betta, F Facciolo, G Tassi, S Tonoli, M Zompatori, ...
American journal of clinical oncology 34 (1), 99-109, 2011
Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: a tissue micro array-based multicenter …
R Lattanzio, R La Sorda, F Facciolo, S Sioletic, L Lauriola, R Martucci, ...
Lung cancer 85 (2), 191-196, 2014
BCL-X L overexpression promotes tumor progression-associated properties
D Trisciuoglio, MG Tupone, M Desideri, M Di Martile, C Gabellini, ...
Cell death & disease 8 (12), 3216, 2017
Prognostic score of long-term survival after surgery for malignant pleural mesothelioma: a multicenter analysis
G Leuzzi, F Rea, L Spaggiari, G Marulli, I Sperduti, G Alessandrini, ...
The Annals of thoracic surgery 100 (3), 890-897, 2015
Magnetic resonance imaging using endoanal coil in anal canal tumors after radiochemotherapy or local excision.
M Indinnimeo, C Cicchini, A Stazi, G Alessandrini, C Ghini, F Fanelli, ...
International surgery 85 (2), 143-146, 2000
G Leuzzi, G Alessandrini, I Sperduti, L Spaggiari, F Venuta, E Rendina, ...
Interactive CardioVascular and Thoracic Surgery 21 (suppl_1), S2-S3, 2015
Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer
A Prodosmo, A Buffone, M Mattioni, A Barnabei, A Persichetti, A De Leo, ...
Journal of Experimental & Clinical Cancer Research 35 (1), 135, 2016
Expectoration of the staple line: a delayed complication after previous lobectomy
G Leuzzi, G Alessandrini, D Forcella, F Facciolo
Interactive cardiovascular and thoracic surgery 20 (5), 672-674, 2015
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome
S Di Martino, CA Amoreo, B Nuvoli, R Galati, S Strano, F Facciolo, ...
Oncogene 37 (10), 1369, 2018
Induction therapy versus initial surgery in advanced thymic tumors: Perioperative and oncological outcome
G Leuzzi, G Alessandrini, I Sperduti, D Forcella, M Marino, A Ceribelli, ...
The Thoracic and cardiovascular surgeon 65 (03), 234-243, 2017
CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions
S Bruschini, S di Martino, ME Pisanu, L Fattore, C De Vitis, V Laquintana, ...
Journal of Cellular Physiology, 2019
What determines the complication rate in high-risk chronic obstructive pulmonary disease patients: surgery or pulmonary function?
M Chiappetta, D Forcella, G Alessandrini, F Facciolo
European Journal of Cardio-Thoracic Surgery 51 (1), 194-195, 2016
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20